{"product_id":"2023-2028-france-hematology-and-flow-cytometry-analyzers-and-reagents-market-2023-supplier-shares-2023-2028-test-volume-and-sales-segment-forecasts-for-over-40-individual-tests-performed-in-hospitals-commercial-private-labs-poc-locations-competitive","title":"2023-2028 France Hematology and Flow Cytometry Analyzers and Reagents Market - 2023 Supplier Shares, 2023-2028 Test Volume and Sales Segment Forecasts for over 40 Individual Tests Performed in Hospitals, Commercial\/Private Labs, POC Locations—Competitive","description":"\u003cp\u003e2023-2028 France Hematology and Flow Cytometry Analyzers and Reagents Market - 2023 Supplier Shares, 2023-2028 Test Volume and Sales Segment Forecasts for over 40 Individual Tests Performed in Hospitals, Commercial\/Private Labs, POC Locations—Competitive Strategies, Instrumentation Pipeline, Emerging Technologies, Opportunities for Suppliers, Market Challenges \u003cbr\u003e\nThis unique report from LeadingMarketResearch.com provides information and analysisnot available from any other published source.\u003c\/p\u003e\n\n\u003cp\u003eLeadingMarketResearch.com's new study is designed to help current suppliers and potential market entrants identify and evaluate business opportunities emerging in the French hematology and flow cytometry markets during the next five years.\u003c\/p\u003e\n\n\u003cp\u003eThe report explores business and technological trends in the French market; provides market share estimates, as well as specimen, test, sales forecasts, and instrument placements; compares features of major analyzers; profiles leading competitors and emerging market entrants; and suggests specific product and marketing opportunities facing reagent and instrument suppliers.\u003c\/p\u003e\n\n\u003cp\u003eRationale\u003c\/p\u003e\n\n\u003cp\u003eDuring the next five years, continued advances in molecular diagnostics, monoclonal antibodies, lasers and IT, as well as growing understanding of immunologic forces regulating systemic diseases, will have a profound impact on the hematology and flow cytometry markets worldwide. New molecular diagnostic and monoclonal antibody tests will facilitate existing procedures and provide basis for sensitive, specific and simple assays. The introduction of smaller and easy-to-operate laser systems will further expand applications of flow cytometry to routine clinical laboratories. Further advances in IT will reduce the cost of instrument manufacture, service warranty, and permit development of self-troubleshooting, autocalibration and other advanced features. Presently tedious analyses of chromosomal abnormalities, DNA content, and lymphocyte subsets will become more automated and routine.\u003c\/p\u003e\n\n\u003cp\u003eFrench Market Overview\u003c\/p\u003e\n\n\u003cp\u003eFacilities performing hematology and flow cytometry testing.\u003cbr\u003e\nTest volume and sales projections.\u003c\/p\u003e\n\n\u003cp\u003eStrategic Recommendations\u003c\/p\u003e\n\n\u003cp\u003eNew product development opportunities with significant market appeal.\u003cbr\u003e\nAlternative market penetration strategies.\u003cbr\u003e\nPotential market entry barriers and risks.\u003c\/p\u003e\n\n\u003cp\u003eMarket Segmentation Analysis\u003c\/p\u003e\n\n\u003cp\u003eSales and market share estimates for leading suppliers of hematology and flow cytometry products by country.\u003c\/p\u003e\n\n\u003cp\u003eSpecimen, test and sales forecasts for over 40 procedures by individual test and market segment:\u003c\/p\u003e\n\n\u003cp\u003eHospitals\u003cbr\u003e\nCommercial\/Private LaboratoriesSales and Market Share Analysis\u003c\/p\u003e\n\n\u003cp\u003eSales and market shares of major instrument and reagent suppliers.\u003c\/p\u003e\n\n\u003cp\u003eHematology Tests\u003c\/p\u003e\n\n\u003cp\u003eCBC + 5-Part Differential, Manual Differential\/Review, Hematocrit (Automated, Manual), Hemoglobin (Automated, Manual), Sedimentation Rate, Reticulocytes, WBC (Automated, Manual), Platelets (Automated, Manual), Bone Marrow Analysis, RBC, Eosinophils.\u003c\/p\u003e\n\n\u003cp\u003eFlow Cytometry Tests\u003c\/p\u003e\n\n\u003cp\u003eCell Surface Markers (CD4\/CD8\/T\u0026amp;B Lymphocytes, CD34, Others), Chemotherapy Monitoring (Leukemia\/Lymphoma, Others), HLA Typing, Sperm Analysis, Cell Cycle Kinetics, Cell Function Testing, Chromosomal Abnormalities, Fetal Cell Analysis, Granulocyte Function, Receptor DNA\/RNA Analysis, Cell Culturing.\u003c\/p\u003e\n\n\u003cp\u003eCurrent and Emerging Products\u003c\/p\u003e\n\n\u003cp\u003eAnalysis of current and emerging hematology and flow cytometry assays.\u003cbr\u003e\nReagent and instrument sales forecasts by market segment.\u003cbr\u003e\nInstrument placements and installed base by manufacturer and model.\u003cbr\u003e\nSales and market shares of reagent and instrument suppliers.\u003c\/p\u003e\n\n\u003cp\u003eInstrumentation Review\u003c\/p\u003e\n\n\u003cp\u003eThe study reviews current instrumentation technologies, and compares features of leading hematology, flow cytometry, platelet aggregation and sedimentation rate analyzers.\u003c\/p\u003e\n\n\u003cp\u003eThe report features analyzers manufactured by Abbott, Beckman Coulter\/Danaher, Becton Dickinson, Biocode Hycel, CellaVision, Diesse Ves Matic, Drew-Scientific, Horiba, Medica, Menarini, Nihon Kohden, Polymedco, Siemens and Sysmex.\u003c\/p\u003e\n\n\u003cp\u003eTechnology Review\u003c\/p\u003e\n\n\u003cp\u003eAssessment of current and emerging technologies and their potential market applications.\u003c\/p\u003e\n\n\u003cp\u003eComprehensive lists of companies developing or marketing new technologies and products by test.\u003c\/p\u003e\n\n\u003cp\u003eCompetitive Assessments\u003c\/p\u003e\n\n\u003cp\u003eExtensive strategic profiles of major suppliers and emerging market entrants.\u003c\/p\u003e\n\n\u003cp\u003eThe companies analyzed in the report include:\u003c\/p\u003e\n\n\u003cp\u003eAbbott\u003cbr\u003e\nAgilent Technologies\u003cbr\u003e\nBeckman Coulter\/Danaher\u003cbr\u003e\nBecton Dickinson\u003cbr\u003e\nBio-Rad\u003cbr\u003e\nCellaVision\u003cbr\u003e\nHoriba\u003cbr\u003e\nMindray\u003cbr\u003e\nNihon Kohden\u003cbr\u003e\nQuidelOrtho\u003cbr\u003e\nRoche\u003cbr\u003e\nSekisui Diagnostics\u003cbr\u003e\nSiemens Healthineers\u003cbr\u003e\nSysmex\u003c\/p\u003e\n\n\u003cp\u003ePlease note: The delivery time for the electronic version of this report is between 1-3 business days to allow the preparation of an updated version prior to dispatch.\u003c\/p\u003e","brand":"Life Science","offers":[{"title":"October, 2023 \/ - \/ MCW16256284","offer_id":47650522497330,"sku":null,"price":2220.0,"currency_code":"USD","in_stock":true}],"url":"https:\/\/www.hardmanwell.com\/products\/2023-2028-france-hematology-and-flow-cytometry-analyzers-and-reagents-market-2023-supplier-shares-2023-2028-test-volume-and-sales-segment-forecasts-for-over-40-individual-tests-performed-in-hospitals-commercial-private-labs-poc-locations-competitive","provider":"HARDMAN AND WELL MANAGEMENT CONSULTANCIES L.L.C","version":"1.0","type":"link"}